Literature DB >> 20025891

Profile of TP53 gene mutations in sinonasal cancer.

Reetta Holmila1, Jette Bornholdt, Tuula Suitiala, Diane Cyr, Michael Dictor, Torben Steiniche, Henrik Wolff, Håkan Wallin, Danièle Luce, Kirsti Husgafvel-Pursiainen.   

Abstract

Genetic alterations underlying the development of the cancer of the nose and paranasal sinuses (sinonasal cancer, SNC), a rare cancer that can be included in the group of head and neck cancers, are still largely unknown. We recently reported that TP53 mutations are a common feature of SNC, with an overall frequency of 77%, and they show association to adenocarcinoma and wood-dust exposure [15]. In this study, we report in detail the sequence change for 159 TP53 mutations identified by direct sequencing. More than half of the mutations (60%, 95/159) were missense mutations; there were also 28 (18%) frameshift or nonsense mutations, and 36 (23%) intronic or silent mutations. In coding region, the most common base change detected was C-->T transition (43/125; 34% of base changes in the coding region). G-->T transversions occurred at a frequency of 10% (12/125), which is less than reported in mutation databases for head and neck squamous cell carcinoma (24%). Characteristically, in our SNC series, the mutations were scattered over a large number of codons, codon 248 being the most frequent target of base substitution. Codon 135 was the second most frequently mutated codon; this nucleotide position has not been reported before as frequently mutated in head and neck cancer or human cancer in general. About half of all tumours with TP53 mutations carried more than one mutation. Interestingly, 86% (19/22) of the silent mutations detected had occurred in tumours with multiple mutations. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20025891     DOI: 10.1016/j.mrfmmm.2009.12.003

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  8 in total

1.  Genetic variations in XRCC1 gene in sporadic head and neck cancer (HNC) patients.

Authors:  Ishrat Mahjabeen; Ruqia Mehmood Baig; Nosheen Masood; Maimoona Sabir; Uzma Inayat; Faraz Arshad Malik; Mahmood Akhtar Kayani
Journal:  Pathol Oncol Res       Date:  2012-09-29       Impact factor: 3.201

2.  Establishment and genetic characterization of an immortal tumor cell line derived from intestinal-type sinonasal adenocarcinoma.

Authors:  Jhudit Pérez-Escuredo; Jorge García Martínez; Cristina García-Inclán; Blanca Vivanco; María Costales; César Álvarez Marcos; José Luis Llorente; Mario A Hermsen
Journal:  Cell Oncol (Dordr)       Date:  2011-01-18       Impact factor: 6.730

3.  Mutation frequency in 15 common cancer genes in high-risk head and neck squamous cell carcinoma.

Authors:  Sean M McBride; S Michael Rothenberg; William C Faquin; Annie W Chan; John R Clark; Leif W Ellisen; Lori J Wirth
Journal:  Head Neck       Date:  2014-03-10       Impact factor: 3.147

4.  Combined Neuroendocrine and Squamous Cell Carcinoma of the Sinonasal Tract: A Morphologic and Immunohistochemical Analysis and Review of Literature.

Authors:  Shweta Agarwal; Annemieke van Zante; Michaela L Granados
Journal:  Head Neck Pathol       Date:  2022-05-04

5.  Primary combined neuroendocrine and squamous cell carcinoma of the maxillary sinus: report of a case with immunohistochemical and molecular characterization.

Authors:  Alessandro Franchi; Davide Rocchetta; Annarita Palomba; Duccio Rossi Degli Innocenti; Francesca Castiglione; Giuseppe Spinelli
Journal:  Head Neck Pathol       Date:  2013-12-11

6.  Clonal evolution of a case of treatment refractory maxillary sinus carcinoma.

Authors:  Shilpi Arora; Ronald L Korn; Elizabeth Lenkiewicz; Irene Cherni; Thomas G Beach; Galen Hostetter; Michael T Barrett; Glen J Weiss
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

7.  Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma.

Authors:  N Nohata; T Hanazawa; N Kikkawa; D Sakurai; L Fujimura; T Chiyomaru; K Kawakami; H Yoshino; H Enokida; M Nakagawa; A Katayama; Y Harabuchi; Y Okamoto; N Seki
Journal:  Br J Cancer       Date:  2011-08-16       Impact factor: 7.640

8.  Hspb1 and Tp53 Mutation and Expression Analysis in Cat Mammary Tumors.

Authors:  Rashid Saif; Ali Raza Awan; Leslie Lyons; Barbara Gandolfi; Muhammad Tayyab; Masroor Ellahi Babar; Asim Khalid Mehmood; Zia Ullah; Muhammad Wasim
Journal:  Iran J Biotechnol       Date:  2016-09       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.